Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Meiji

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Meiji's Japan sales performance.

Chinese biotechs aim PD-L1 antibody at hepatitis B

Chinese biotechs aim PD-L1 antibody at hepatitis B

Suzhou Alphamab is already testing its PD-L1 inhibitor antibody KN035 in a number of clinical trials across tumour types in the US, China and Japan, but has licensed rights for

Relearning launch: Four key dynamics for pharma launches in 2019

Relearning launch: Four key dynamics for pharma launches in 2019 Japan is recalibrating its traditional national quantitative approach to care decisions with a new regional approach to qualitative health and quality-of-life targets.

Ashfield joins forces with Argon Global Healthcare Network

Ashfield joins forces with Argon Global Healthcare Network Doug Burcin, President, Ashfield Healthcare Communications. “We have a well-established presence in the UK, Germany, Japan and US for delivering our solutions at the intersection of science, data and creativity

Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO inflammation test for managing asthma, across key markets such as the United States, China, and Japan, as well as the rest of the world.

Takeda secures investor backing for £46bn Shire takeover

Takeda secures investor backing for £46bn Shire takeover After a gruelling two and a half hour meeting held in Osaka, Japan, almost 90% of shareholders agreed to the takeover, but the decision was met with some resistance. ... Weber is adamant that Shire will help Takeda grow outside Japan, swelling the

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics